Clinical Trials Browser

OTHER × Prostatic Neoplasms × Flutamide × Clear all

NCT04513717 2026-04-03

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Phase 3 Active not recruiting

Prostatic Neoplasms

NCT05700903 2026-03-02

ARCH

Phase 4 Completed

Hypertension, Kidney Diseases, Prostatic Neoplasms, Primary Dysautonomias

NCT01786265 2026-02-20

Finite Androgen Ablation With or Without Abiraterone Acetate and Prednisone in Treating Patients With Recurrent Prostate Cancer

Phase 2 Active not recruiting

Prostatic Neoplasms

NCT03507608 2025-10-16

Assessing Induction of Double Strand Breaks With Androgen Receptor Partial Agonist in Patients on Androgen Suppression

Phase EARLY_PHASE1 Completed

25 enrolled 4 charts

Prostatic Neoplasms

NCT06601205 2024-09-19

2F

Phase 2/3 Completed

Prostatic Neoplasms, Prostatic Intraepithelial Neoplasia

NCT00002889 2023-08-18

Radiation Therapy With Androgen Suppression in Treating Patients With Prostate Cancer

Phase 2 Completed

Prostatic Neoplasms

NCT00116220 2022-01-06

Study of External Beam Radiation Therapy With and Without Hormonal Therapy to Treat Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT04248621 2021-07-29

Androgen Deprivation Therapy on Bone Mineral Density Change in Prostate Cancer Patients

Phase 4 Unknown

Prostatic Neoplasms

NCT00104741 2021-02-21

Triptorelin, Flutamide, and External-Beam Radiation Therapy or External-Beam Radiation Therapy Alone in Treating Patients With Stage II or Stage III Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT02742675 2020-07-07

Androgen Deprivation Therapy or Androgen Deprivation Therapy Plus Definitive Treatment (Radiation or Surgery)

Phase 2 Unknown

Prostatic Neoplasms

NCT00003645 2020-04-28

Randomized Trial of Adjuvant Hormonal Therapy in Surgically Treated Prostate Cancer Patients at High Risk for Recurrence

Phase 3 Terminated

64 enrolled 12 charts

Prostatic Neoplasms

NCT00002855 2018-10-31

Chemotherapy Plus Hormone Therapy Versus Androgen Suppression in Treating Patients With Metastatic or Unresectable Prostate Cancer

Phase 3 Completed

Prostatic Neoplasms

NCT00223665 2018-08-07

IAS

Phase 2 Completed

102 enrolled 21 charts

Prostatic Neoplasms

NCT00283803 2018-08-07

Exisulind and Intermittent Androgen Suppression (ADT) in Biochemical Relapsed Prostate Cancer

Phase 2 Completed

32 enrolled 9 charts

Prostatic Neoplasms

NCT00170157 2017-05-15

Hormone Therapy and Ipilimumab in Treating Patients With Advanced Prostate Cancer

Phase 2 Completed

112 enrolled 6 charts

Prostatic Neoplasms

NCT00006214 2016-07-13

Flutamide In the Prevention of Prostate Cancer in Patients With Neoplasia of the Prostate

Phase 2 Completed

Prostatic Neoplasms

NCT00003323 2016-07-04

Hormone Therapy in Treating Patients With Prostate Cancer

Phase 2 Completed

GenitourinaryOther

Infertility, Prostatic Neoplasms, Sexual Dysfunction, Physiological

NCT00026377 2013-09-05

SU5416 Plus Hormone Therapy and Radiation Therapy in Treating Patients With Prostate Cancer

Phase 1 Completed

Prostatic Neoplasms

NCT00388804 2012-08-08

External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer

Phase 3 Terminated

39 enrolled 3 charts

Prostatic Neoplasms